John Desjardins

Biological Effects of Short-Term or Prolonged Administration of 9-[2-(Phosphonomethoxy)Propyl]Adenine (Tenofovir) to Newborn and Infant Rhesus Macaques

Koen K. A. Van Rompay, Laurie Brignolo, Dennis J. Meyer et al. · Antimicrobial Agents and Chemotherapy · 2004 · 141 citations · Full text

Medicine, Pharmacology, Pharmacodynamics +3

Evaluation of mitochondrial DNA content and enzyme levels in tenofovir DF-treated rats, rhesus monkeys and woodchucks

Greg Biesecker, Susan Karimi, John Desjardins et al. · Antiviral Research · 2003 · 66 citations

Life Sciences, Biochemistry, Genetics +9

Antitumor efficacy, pharmacokinetics, and biodistribution of NX 211: a low-clearance liposomal formulation of lurtotecan.

David L. Emerson, Raymond A. Bendele, Eric Brown et al. · PubMed · 2000 · 61 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Mice deficient for cytosolic thymidine kinase gene develop fatal kidney disease

Vasily N. Dobrovolsky, Thomas J. Bucci, Robert H. Heflich et al. · Molecular Genetics and Metabolism · 2003 · 58 citations

Medicine, Genetics, Molecular Biology +14

Cholesteryl-Conjugated Phosphorothioate Oligodeoxynucleotides Modulate CYP2B1 Expression<i>In Vivo</i>

John Desjardins, John E. Mata, Tom Brown et al. · Journal of drug targeting · 1995 · 36 citations

Medicine, Pharmacokinetics, Pharmacology +12